ICD-10-CM | Description |
---|---|
Malignant neoplasm of gastric antrum | |
C16.4 | Malignant neoplasm of pylorus |
Malignant neoplasm of prepylorus | |
Malignant neoplasm of pyloric canal |
A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere.
The 2022 edition of ICD-10-CM C16.9 became effective on October 1, 2021.
For multiple neoplasms of the same site that are not contiguous, such as tumors in different quadrants of the same breast, codes for each site should be assigned. Malignant neoplasm of ectopic tissue. Malignant neoplasms of ectopic tissue are to be coded to the site mentioned, e.g., ectopic pancreatic malignant neoplasms are coded to pancreas, ...
A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere.
Gastrointestinal stromal tumor, unspecified site 1 C49.A0 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. 2 The 2021 edition of ICD-10-CM C49.A0 became effective on October 1, 2020. 3 This is the American ICD-10-CM version of C49.A0 - other international versions of ICD-10 C49.A0 may differ.
The 2022 edition of ICD-10-CM C49.A0 became effective on October 1, 2021.
Gastrointestinal cancer refers to malignant conditions of the gastrointestinal tract (GI tract) and accessory organs of digestion, including the esophagus, stomach, biliary system, pancreas, small intestine, large intestine, rectum and anus. The symptoms relate to the organ affected and can include obstruction ...
Billable codes are sufficient justification for admission to an acute care hospital when used a principal diagnosis.
The 2022 edition of ICD-10-CM K92.2 became effective on October 1, 2021.
A disorder characterized by bleeding from the gastric wall.
C26.9 is a billable diagnosis code used to specify a medical diagnosis of malignant neoplasm of ill-defined sites within the digestive system. The code C26.9 is valid during the fiscal year 2021 from October 01, 2020 through September 30, 2021 for the submission of HIPAA-covered transactions.#N#The ICD-10-CM code C26.9 might also be used to specify conditions or terms like malignant neoplasm of digestive system, malignant neoplasm of gastrointestinal tract, malignant neoplasm, overlapping lesion of digestive system, malignant tumor of digestive organ, mucinous adenocarcinoma of gastrointestinal tract , overlapping malignant neoplasm of gastrointestinal tract, etc.#N#The following anatomical sites found in the Table of Neoplasms apply to this code given the correct histological behavior: Neoplasm, neoplastic alimentary canal or tract NEC or Neoplasm, neoplastic digestive organs, system, tube, or tract NEC or Neoplasm, neoplastic gastrocolic or Neoplasm, neoplastic gastrointestinal (tract) NEC or Neoplasm, neoplastic peritoneum, peritoneal (cavity) overlapping lesion with digestive organs .
FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016 (First year ICD-10-CM implemented into the HIPAA code set)
The code C26.9 is included in the table of neoplasms by anatomical site. For each site there are six possible code numbers according to whether the neoplasm in question is malignant, benign, in situ, of uncertain behavior, or of unspecified nature. The description of the neoplasm will often indicate which of the six columns is appropriate.#N#Where such descriptors are not present, the remainder of the Index should be consulted where guidance is given to the appropriate column for each morphological (histological) variety listed. However, the guidance in the Index can be overridden if one of the descriptors mentioned above is present.
Also called: Carcinoma, Malignancy, Neoplasms, Tumor. Cancer begins in your cells, which are the building blocks of your body. Normally, your body forms new cells as you need them, replacing old cells that die. Sometimes this process goes wrong.